With a better understanding of the neurobiology of migraine and the 5-hydroxytryptamine (5-HT) receptor, or serotonin receptor, the burden on patients with migraine has been lightened with the creation of selective 5-HT1B/1D agonists called triptans [3]. Here, HTR1B is linked to migraine disorder.